Respiratory News and Research

RSS

Ragweed pollen can trigger strong allergic reactions

Ragweed (Ambrosia artemisiifolia) - an otherwise unremarkable plant - produces pollen that can trigger strong allergic reactions such as asthma even in very small quantities. Scientists from Technische Universität München (TUM) and Helmholtz Zentrum München have now published a joint study showing that the substance previously identified as the major allergen only induces such a vigorous allergic response in combination with the adenosine also present in the pollen.

18 Jun 2015

Public health experts outline strategies for managing MERS-CoV outbreak

The ongoing outbreak in the Republic of Korea (South Korea) is an important reminder that the Middle East respiratory virus (MERS-CoV) requires constant vigilance and could spread to other countries including the United States. However, MERS can be brought under control with effective public health strategies, say two Georgetown University public health experts.

18 Jun 2015

Warm Springs Specialty Hospital of New Braunfels achieves Gold Seal of Approval for Respiratory Failure Certification

Warm Springs Specialty Hospital of New Braunfels, a Post Acute Medical facility, today announced that it has earned The Joint Commission's Gold Seal of Approval for Respiratory Failure Certification. The Gold Seal of Approval is a symbol of quality that reflects an organization's commitment to providing safe and effective patient care.

17 Jun 2015

Hill-Rom, Welch Allyn joining forces to advance patient care around the world

Two of the world's leading healthcare technology companies are joining forces to make possible the development of leading-edge solutions that will advance patient care around the world. Hill-Rom Holdings, Inc. and privately-held Welch Allyn, Inc. today announced that the Boards of Directors of both companies have unanimously approved a definitive agreement under which Hill-Rom will acquire Welch Allyn for approximately $2.05 billion in cash and stock.

17 Jun 2015

New research looks at quickly expanding effort to equip law enforcement officers with naloxone

Opioid overdose is one of the leading causes of accidental death in the U.S. According to the Centers for Disease Control and Prevention, the epidemic accounts for some 25,000 deaths per year--or approximately 68 fatalities per day.

17 Jun 2015

Pulmatrix signs ex-U.S. development agreement with Mylan for bronchodilator therapy

Pulmatrix, a clinical stage biopharmaceutical company developing innovative inhaled therapies for serious pulmonary diseases, today announced that it has entered into an ex-U.S. development agreement with Mylan N.V., one of the world's leading global pharmaceutical companies.

16 Jun 2015

Improving air quality could prevent pollution-related deaths worldwide

Improving air quality -- in clean and dirty places -- could reduce pollution-related deaths worldwide by millions of people each year. That finding comes from a team of environmental engineering and public health researchers who developed a global model of how changes in outdoor air pollution could lead to changes in the rates of health problems such as heart attack, stroke and lung cancer.

16 Jun 2015

Critical care Breathe Technologies Life2000 Ventilation System receives FDA clearance

Breathe Technologies, Inc., a developer and manufacturer of medical technologies for patients with respiratory insufficiency and neuromuscular diseases, announced today that the U.S. Food and Drug Administration has granted 510(k) clearance for its critical care Breathe Technologies Life2000 Ventilation System, which is intended to provide continuous or intermittent ventilatory support for the care of individuals who require mechanical ventilation.

15 Jun 2015

Laurent reports positive topline results from LAU-7b Phase 1b trial in adult CF patients

Laurent Pharmaceuticals Inc. announced today positive topline results from a Phase 1b clinical trial with LAU-7b in adult CF patients. LAU-7b is a novel oral formulation of fenretinide, a synthetic retinoid investigated for its lipid modulating properties and potential to address the aberrant inflammatory response in CF.

15 Jun 2015

Genesis inks asset purchase agreement with Revera

Genesis HealthCare, one of the nation's largest providers of post-acute care, today announced that it has signed an asset purchase agreement with Revera Inc., a leading owner, operator and investor in the senior living sector, to acquire 24 of its skilled nursing facilities along with its contract rehabilitation business for $240 million.

15 Jun 2015

American Thoracic Society releases recommendations on achieving good quality sleep

The American Thoracic Society has released a policy statement with recommendations for clinicians and the general public on achieving good quality sleep and getting an adequate quantity of sleep.

15 Jun 2015

Triciribine drug may reverse progression of pulmonary fibrosis and pulmonary hypertension

Researchers at the University of Georgia have discovered that the drug triciribine may reverse or halt the progression of pulmonary fibrosis and pulmonary hypertension, two respiratory diseases that are almost invariably fatal.

13 Jun 2015

Promising results for multi-source DBS in Parkinson’s disease

Deep-brain stimulation targeting the subthalamic nucleus with a multiple-source constant-current device effectively suppresses motor symptoms in patients with advanced Parkinson’s disease, report researchers.

12 Jun 2015

Older asthmatic patients treated with inhaled corticosteroids at increased risk for treatment failure

Older patients with asthma are at increased risk for treatment failure, particularly those patients being treated with inhaled corticosteroids, according to a new study.

12 Jun 2015

Study seeks to determine environmental factors that protect against asthma, allergies

Researchers in the University of Arizona's BIO5 Institute have entered into a collaboration with Johnson & Johnson Consumer & Personal Products and Janssen Biotech Inc. to leverage foundational discovery research aimed at determining environmental factors that underlie asthma and allergies.

12 Jun 2015

Peanut and nut intake lowers risk of dying from major causes of death

A paper published today in the International Journal of Epidemiology confirms a link between peanut and nut intake and lower mortality rates, but finds no protective effect for peanut butter. Men and women who eat at least 10 grams of nuts or peanuts per day have a lower risk of dying from several major causes of death than people who don't consume nuts or peanuts.

11 Jun 2015

Researchers identify two critical mutations that allow MERS virus to transmit from bats to humans

Researchers have identified two critical mutations allowing the deadly Middle East Respiratory Syndrome (MERS) virus to transmit from bats to humans. The findings were published in the most recent edition of the Journal of Virology.

11 Jun 2015

Patients with community-acquired pneumonia have high rates of long-term morbidity and mortality

Having had community-acquired pneumonia (CAP) greatly increases the risk of long-term morbidity and mortality compared to the general population who have never had CAP, according to a new study from researchers in Canada, the longest and largest outcomes study of patients with CAP reported to date.

11 Jun 2015

Isis Pharmaceuticals provides update on ISIS-SMN Rx Phase 2 clinical study in infants with Type I SMA

Isis Pharmaceuticals, Inc. today provided an update on its ongoing open-label Phase 2 clinical study of ISIS-SMN Rx in infants with Type I spinal muscular atrophy (SMA).

11 Jun 2015

Data from statewide quality collaborative helps surgeons to reduce rates of serious trauma complication

As health insurers place more emphasis on paying for quality outcomes rather than for specific services provided by doctors and hospitals, several quality improvement programs have been developed as a way to help health care providers identify problem areas and share best practices. While some studies have evaluated how well these quality improvement programs achieve their goals, not many have focused on the area of trauma care.

11 Jun 2015

Respiratory News and Research

Ragweed pollen can trigger strong allergic reactions

Public health experts outline strategies for managing MERS-CoV outbreak

Warm Springs Specialty Hospital of New Braunfels achieves Gold Seal of Approval for Respiratory Failure Certification

Hill-Rom, Welch Allyn joining forces to advance patient care around the world

New research looks at quickly expanding effort to equip law enforcement officers with naloxone

Pulmatrix signs ex-U.S. development agreement with Mylan for bronchodilator therapy

Improving air quality could prevent pollution-related deaths worldwide

Critical care Breathe Technologies Life2000 Ventilation System receives FDA clearance

Laurent reports positive topline results from LAU-7b Phase 1b trial in adult CF patients

Genesis inks asset purchase agreement with Revera

American Thoracic Society releases recommendations on achieving good quality sleep

Triciribine drug may reverse progression of pulmonary fibrosis and pulmonary hypertension

Promising results for multi-source DBS in Parkinson’s disease

Older asthmatic patients treated with inhaled corticosteroids at increased risk for treatment failure

Study seeks to determine environmental factors that protect against asthma, allergies

Peanut and nut intake lowers risk of dying from major causes of death

Researchers identify two critical mutations that allow MERS virus to transmit from bats to humans

Patients with community-acquired pneumonia have high rates of long-term morbidity and mortality

Isis Pharmaceuticals provides update on ISIS-SMN Rx Phase 2 clinical study in infants with Type I SMA

Data from statewide quality collaborative helps surgeons to reduce rates of serious trauma complication

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News